Lisata Therapeutics earnings were -$21.1M for the trailing 12 months ending Jun 30, 2024, with N/A growth year over year. The latest LSTA earnings report on Jun 30, 2024 announced Q2 2024 earnings of -$5.0M, down 6.6% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, LSTA reported annual earnings of -$20.8M, with -61.6% growth. The next LSTA earnings date is Oct 31, 2024.
Lisata Therapeutics Earnings Reports & History FAQ
What were Lisata Therapeutics's earnings last quarter?
On LSTA's earnings call on Invalid Date, Lisata Therapeutics (NASDAQ: LSTA) reported Q2 2024 earnings per share (EPS) of -$0.61, up 22% year over year. Total LSTA earnings for the quarter were -$5.04 million. In the same quarter last year, Lisata Therapeutics's earnings per share (EPS) was -$0.50.
The next LSTA earnings date is Invalid Date. Add LSTA to your watchlist to be reminded of Lisata Therapeutics's next earnings date.
Is Lisata Therapeutics profitable or losing money?
As of the last Lisata Therapeutics earnings report, Lisata Therapeutics is currently losing money. Lisata Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2024 was -$21.07 million, a 60.68% decrease year over year.
What was LSTA's earnings growth in the past year?
As of Lisata Therapeutics's earnings date in Invalid Date, Lisata Therapeutics's earnings has grown year over year. LSTA earnings in the past year totalled -$21.07 million.
What are Lisata Therapeutics's earnings expectations?
The current EPS estimate for Lisata Therapeutics's earnings report in Invalid Date is -$0.77.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.